Shin_2005_J.Pharmacol.Sci_99_117

Reference

Title : Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice - Shin_2005_J.Pharmacol.Sci_99_117
Author(s) : Shin EJ , Jhoo JH , Nabeshima T , Jhoo WK , Kwon MS , Lim YK , Chae JS , Jung ME , Park SJ , Jang KJ , Kim HC
Ref : J Pharmacol Sci , 99 :117 , 2005
Abstract :

Accumulating evidence indicates that growth hormone (GH) might be effective at preventing the development of Alzheimer's disease. However, exogenous GH treatment has exhibited side effects for clinical application; thus supplementation with amino acids to promote the release of GH could be a possible alternative treatment. In this study, mice that were fed with a diet of GH-releasing supplements had significantly attenuated memory impairments and hippocampal changes in the acetylcholinesterase activity and acetylcholine level induced by amyloid beta protein (Abeta) (1 - 42). Our results suggest that the use of GH-releasing supplement exerts beneficial effects on the memory impairment induced by Abeta (1 - 42).

PubMedSearch : Shin_2005_J.Pharmacol.Sci_99_117
PubMedID: 16141634

Related information

Citations formats

Shin EJ, Jhoo JH, Nabeshima T, Jhoo WK, Kwon MS, Lim YK, Chae JS, Jung ME, Park SJ, Jang KJ, Kim HC (2005)
Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice
J Pharmacol Sci 99 :117

Shin EJ, Jhoo JH, Nabeshima T, Jhoo WK, Kwon MS, Lim YK, Chae JS, Jung ME, Park SJ, Jang KJ, Kim HC (2005)
J Pharmacol Sci 99 :117